# Novartis d.o.o. – FDA Inspection, Feb 9, 2024

Source: https://www.keypedia.com/records/fda_inspections/novartis-doo/b15c18b8-94c8-4b0b-bfb1-8e8b16a99cbf
Source feed: FDA_Inspections

> FDA inspection 1229017 of Novartis d.o.o., February 09, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1229017
- Company Name: Novartis d.o.o.
- Inspection Date: 2024-02-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1230625 - 2023-01-25](https://www.keypedia.com/records/fda_inspections/novartis-doo/a9649b50-4b34-4eda-956b-b7cf72548b65)

## Related Officers

- [Bijoy Panicker](https://www.keypedia.com/people/bijoy-panicker/1c6ec57f-e02e-49b8-8b59-1853f3d2947a)
- [Issuing Officer](https://www.keypedia.com/people/haitao-li/62ce7565-d80f-4570-962a-8e6bfc88d0c1)

Company: https://www.keypedia.com/companies/novartis-doo/d4f5147d-097a-4bd5-9ee0-25ff7a6cb638

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
